Skip to main content

Pro Sci Incorporated

Founded in 1998 and located in San Diego, ProSci has utilized its infectious disease expertise to develop high-quality antibodies, recombinant proteins, and reagents for a number of research areas. To date, ProSci has an antibody catalog of over 30,000 primary antibodies and was one of the first companies to market COVID-19 products with SARS-CoV-2 reagents.